You may be given other standard drugs to help lower the risk of side effects. Also, if the doctor thinks it is appropriate based on having the CD20 protein on specific blood cells (CD20+ disease), you will receive standard therapy with rituximab. You may ask the study staff for more information about how these drugs are given and their risks.